Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fresh whole blood use for hemorrhagic shock: preserving benefit while avoiding complications.
Spinella PC, Reddy HL, Jaffe JS, Cap AP, Goodrich RP. Spinella PC, et al. Among authors: goodrich rp. Anesth Analg. 2012 Oct;115(4):751-8. doi: 10.1213/ANE.0b013e318261f40e. Epub 2012 Jul 4. Anesth Analg. 2012. PMID: 22763908 Review.
Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
Fast LD, Nevola M, Tavares J, Reddy HL, Goodrich RP, Marschner S. Fast LD, et al. Among authors: goodrich rp. Transfusion. 2013 Feb;53(2):373-81. doi: 10.1111/j.1537-2995.2012.03715.x. Epub 2012 May 21. Transfusion. 2013. PMID: 22612327
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
Reddy HL, Doane SK, Keil SD, Marschner S, Goodrich RP. Reddy HL, et al. Among authors: goodrich rp. Transfusion. 2013 Jan;53 Suppl 1:131S-136S. doi: 10.1111/trf.12047. Transfusion. 2013. PMID: 23301965
Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
Balint B, Jovicic-Gojkov D, Todorovic-Balint M, Subota V, Pavlovic M, Goodrich R. Balint B, et al. Transfus Apher Sci. 2013 Dec;49(3):434-9. doi: 10.1016/j.transci.2013.05.035. Epub 2013 Jun 29. Transfus Apher Sci. 2013. PMID: 23820430
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.
Keil SD, Hovenga N, Gilmour D, Marschner S, Goodrich R. Keil SD, et al. J Vis Exp. 2015 Aug 24;(102):e52820. doi: 10.3791/52820. J Vis Exp. 2015. PMID: 26327141 Free PMC article.
Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.
Yonemura S, Doane S, Keil S, Goodrich R, Pidcoke H, Cardoso M. Yonemura S, et al. Blood Transfus. 2017 Jul;15(4):357-364. doi: 10.2450/2017.0320-16. Epub 2017 May 11. Blood Transfus. 2017. PMID: 28665269 Free PMC article. Review.
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.
Marschner S, Goodrich R. Marschner S, et al. Transfus Med Hemother. 2011;38(1):8-18. doi: 10.1159/000324160. Epub 2011 Jan 31. Transfus Med Hemother. 2011. PMID: 21779202 Free PMC article.
Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function.
Galan AM, Lozano M, Molina P, Navalon F, Marschner S, Goodrich R, Escolar G. Galan AM, et al. Transfusion. 2011 Apr;51(4):808-15. doi: 10.1111/j.1537-2995.2010.02914.x. Epub 2010 Oct 26. Transfusion. 2011. PMID: 20977485
Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R. Cardo LJ, et al. Transfus Apher Sci. 2007 Oct;37(2):131-7. doi: 10.1016/j.transci.2007.07.002. Epub 2007 Oct 22. Transfus Apher Sci. 2007. PMID: 17950672
Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model.
Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, Lippert L, Montgomery J, Richards A, Chan C, Jiang J, Reddy H, Li J, Goodrich R. Rentas F, et al. Transfusion. 2007 Feb;47(2):240-7. doi: 10.1111/j.1537-2995.2007.01094.x. Transfusion. 2007. PMID: 17302769
86 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page